Name | 5-Bromo-2-fluoroanisole |
---|---|
Synonyms |
5-bromo-2-fluoroanisole
2-Fluoro-5-bromoanisole 5-Bromo-2-fluorophenyl methyl ether Benzene, 4-bromo-1-fluoro-2-methoxy- 4-Bromo-1-fluoro-2-methoxybenzene |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 205.8±20.0 °C at 760 mmHg |
Molecular Formula | C7H6BrFO |
Molecular Weight | 205.024 |
Flash Point | 92.5±6.0 °C |
Exact Mass | 203.958603 |
PSA | 9.23000 |
LogP | 2.96 |
Appearance | Liquid |
Vapour Pressure | 0.4±0.4 mmHg at 25°C |
Index of Refraction | 1.519 |
Storage condition | Room temperature. |
Symbol |
GHS07 |
---|---|
Signal Word | Warning |
Hazard Statements | H302-H315-H319-H335-H412 |
Precautionary Statements | P261-P273-P305 + P351 + P338 |
Hazard Codes | Xn |
Risk Phrases | 22-36-52 |
Safety Phrases | 26 |
RIDADR | NONH for all modes of transport |
HS Code | 2909309090 |
~76% 103291-07-2 |
Literature: Bristol-Myers Squibb Company Patent: US2007/3539 A1, 2007 ; Location in patent: Page/Page column 71 ; US 20070003539 A1 |
~70% 103291-07-2 |
Literature: ASTRAZENECA AB; ASTEX THERAPEUTICS LTD Patent: WO2007/58602 A2, 2007 ; Location in patent: Page/Page column 141 ; WO 2007/058602 A2 |
HS Code | 2909309090 |
---|---|
Summary | 2909309090 other aromatic ethers and their halogenated, sulphonated, nitrated or nitrosated derivatives VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:5.5% General tariff:30.0% |